
Johnson & Johnson
JNJ 232.77 (1.88%) 4.38
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $560.33(B)
EV: $593.26(B)
Total Equity: $81.19(B)
Earnings date: Jul-14-2026
P/E: 26.63
Forward P/E: 20.10
P/FCF: 31.50
P/S: 5.82
P/B: 6.90
EPS: $8.7
EPS (fwd): $11.6
FCF/share: $7.4
Revenue/share: $40.0
Book value/share: $33.7
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.68
Current Ratio: 1.00
Gross margin: 68.0%
Operating margin: 26.2%
Net margin: 21.8%
Dividend/share: $5.2
Div. yield: 2.23%
Growth Estimates
Revenue
CAGR: 6.7%FY+1$100.89(B)
FY+2(+6.3%)$107.23(B)
FY+3(+7.0%)$114.77(B)
FY+4(+6.3%)$122.02(B)
FY+5(+7.1%)$130.70(B)
Net Income
CAGR: 9.9%FY+1$28.24(B)
FY+2(+9.5%)$30.92(B)
FY+3(+9.4%)$33.81(B)
FY+4(+9.8%)$37.11(B)
FY+5(+11.2%)$41.27(B)
EPS
CAGR: 10.4%FY+1$11.58
FY+2(+9.8%)$12.71
FY+3(+9.8%)$13.95
FY+4(+10.3%)$15.38
FY+5(+11.8%)$17.20
FCF per share
CAGR: 7.5%FY+1$11.15
FY+2(+11.9%)$12.48
FY+3(+5.1%)$13.11
FY+4(+6.3%)$13.94
FY+5(+6.9%)$14.90
